α-Alkyl-α-amino-β-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1
Authors:
- 1 October 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (20) , 2723-2725
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- α-Amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1Bioorganic & Medicinal Chemistry Letters, 2001
- Matrix Metalloproteinases: Biologic Activity and Clinical ImplicationsJournal of Clinical Oncology, 2000
- In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilageAnnals of the Rheumatic Diseases, 1999
- Discovery of a novel series of selective MMP inhibitors: Identification of the γ-sulfone-thiolsBioorganic & Medicinal Chemistry Letters, 1999
- Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.Journal of Clinical Oncology, 1998
- Metalloproteinase inhibitors and the prevention of connective tissue breakdownPharmacology & Therapeutics, 1996
- A New General Approach to Enantiomerically Pure Cyclic and Open‐Chain (R)‐ and (S)‐α,α‐Disubstituted α‐Amino AcidsHelvetica Chimica Acta, 1992
- Preparation, isolation and X-ray crystallographic structure determination of a stable, crystalline carbonic anhydride of an N-protected α-amino acidJournal of the Chemical Society, Perkin Transactions 1, 1992